Repetitive transcranial magnetic stimulation increases the release of dopamine in the nucleus accumbens shell of morphine-sensitized rats during abstinence

Neuropsychopharmacology

Volumn 29, Issue 11, 2004, Pages 2074-2080

  Erhardt, A ^a   Sillaber, I ^a   Welt, T ^a   Muller M B ^a   Singewald, N ^b   Keck, M E ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Craving; Dopamine; Drug withdrawal; Morphine; rTMS; Sensitization

Indexed keywords

DOPAMINE; MORPHINE;

ABSTINENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DRUG ABUSE; DRUG WITHDRAWAL; HIPPOCAMPUS; LIMBIC CORTEX; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; RELAPSE; REWARD; SENSITIZATION; TRANSCRANIAL MAGNETIC STIMULATION; WITHDRAWAL SYNDROME;

ANIMALS; DOPAMINE; ELECTROMAGNETIC FIELDS; MALE; MORPHINE; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS;

EID: 8444223545     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300493     Document Type: Article

References (60)

1. Acquas E, Di Chiara G (1992). Depression of mesolimbic dopamine transmission and sensitization to morphine during opiate abstinence. J Neurochem 58: 1620-1625.
2. Ahtee L, Attila LM, Carlson KR, Haikala H (1989). Changes in brain monoamine metabolism during withdrawal from chronic oral self-administration of morphine and in response to a morphine challenge in the withdrawn state. J Pharmacol Exp Ther 249: 303-310.
3. Berke JD, Hyman SE (2000). Addiction, dopamine, and the molecular mechanisms of memory. Neuron 25: 515-532.
4. Cadoni C, Di Chiara G (1999). Reciprocal changes in dopamine responsiveness in the nucleus accumbens shell and core and in the dorsal caudate-putamen in rats sensitized to morphine. Neuroscience 90: 447-455.
5. Cheramy A, L'Hirondel M, Godeheu G, Artaud F, Glowinski J (1998). Direct and indirect presynaptic control of dopamine release by excitatory amino acids. Amino Acids 14: 63-68.
6. Crawley JN, Corwin RL (1994). Biological actions of cholecystokinin. Peptides 15: 731-755.
7. Czeh B, Welt T, Fischer AK, Erhardt A, Schmitt W, Muller MB et al (2002). Chronic psychosocial stress and concomitant repetitive transcranial magnetic stimulation: effects on stress hormone levels and adult hippocampal neurogenesis. Biol Psychiatry 52: 1057-1065.
8. De Vries TJ, Shippenberg TS (2002). Neural systems underlying opiate addiction. J Neurosci 22: 3321-3325.
9. Diana M, Muntoni AL, Pistis M, Melis M, Cessa GL (1999). Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal. Eur J Neurosci 11: 1037-1041.
10. Di Chiara G (1999). Drug addiction as dopamine-dependent associative learning disorder. Eur J Pharmacol 375: 13-30.
11. Di Chiara G, Imperato A (1986). Preferential stimulation of dopamine release in the nucleus accumbens by opiates, alcohol, and barbiturates: studies with transcerebral dialysis in freely moving rats. Ann NY Acad Sci 473: 367-381.
12. Eichhammer P, Johann M, Kharraz A, Binder H, Pittrow D, Wodarz N et al (2003). High-frequency repetitive transcranial magnetic stimulation decreases cigarette smoking. J Clin Psychiatry 64: 951-953.
13. Feenstra MGP, Botterblom MHA, van Uum JFM (1998). Local activation of metabotropic glutamate receptors inhibits the handling-induced increased release of dopamine in the nucleus accumbens but not that of dopamine or noradrenaline in the prefrontal cortex: comparison with inhibition of ionotropic receptors. J Neurochem 70: 1104-1113.
14. Greene EC (1963). Anatomy of the Rat. Hafner Publishing Company: New York and London.
15. Grunhaus L, Dannon PN, Schreiber S, Dolberg OH, Amiaz R, Ziv R et al (2000). Repetitive transcranial magnetic Stimulation is as effective as electroconvulsive therapy in the treatment of nondelusional major depressive disorder: an open study. Biol Psychiatry 47: 314-324.
16. Hedges DW, Salyer DL, Higginbotham BJ, Lund TD, Hellewell JL, Ferguson D et al (2002). Transcranial magnetic stimulation (TMS) effects on testosterone, prolactin, and corticosterone in adult male rats. Biol Psychiatry 51: 417-421.
17. Herwig U, Padberg F, Unger J, Spitzer M, Schönfeldt-Lecuona C (2001). Transcranial magnetic Stimulation in therapy studies: examination of the reliability of "standard" coil positioning by neuronavigation. Biol Psychiatry 50: 58-61.
18. Johnson DW, Click SD (1993). Dopamine release and metabolism in nucleus accumbens and striatum of morphine-tolerant and nontolerant rats. Pharmacol Biochem Behav 46: 341-347.
19. Kanno M, Matsumoto M, Togashi H, Yoshioka M, Mano Y (2004). Effects of acute repetitive transcranial magnetic stimulation on dopamine release in the rat dorsolateral striatum. J Neurol Sci 217: 73-81.
20. Keck ME (2003). rTMS as treatment strategy in psychiatric disorders-neurobiological concepts. Clin Neurophysiol 56(Suppl): 100-116.
21. Keck ME, Engelmann M, Müller MB, Henniger MSH, Hermann B, Rupprecht R et al (2000a). Repetitive transcranial magnetic stimulation induces active coping strategies and attenuates the neuroendocrine stress response in rats. J Psychiatr Res 34: 265-276.
22. Keck ME, Sillaber I, Ebner K, Welt T, Toschi N, Kaehler ST et al (2000b). Acute transcranial magnetic stimulation of frontal brain regions selectively modulates the release of vasopressin, biogenic amines and amino acids in the rat brain. Eur J Neurosci 12: 3713-3720.
23. Keck ME, Welt T, Müller MB, Erhardt A, Ohl F, Toschi N et al (2002). Repetitive transcranial magnetic stimulation increases the release of dopamine in the mesolimbic and mesostriatal system. Neuropharmacology 43: 101-109.
24. Keck ME, Welt T, Post A, Müller AB, Toschi N, Wigger A et al (2001). Neuroendocrine and behavioral effects of repetitive transcranial magnetic stimulation in a psychopathological animal model are suggestive of antidepressant-like effects. Neuropsychopharmacology 24: 337-349.
25. Klitenick MA, DeWitte P, Kalivas PW (1992). Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: an in vivo microdialysis study. J Neurosci 12: 2623-2632.
26. Koob GF (2001). Drug addiction, reward dysregulation and allostasis. Br J Pharmacol 134: 195.
27. Maisonneuve IM, Warner LM, Click SD (2001). Biphasic dose-related effects of morphine on dopamine release. Drug Alcohol Depend 65: 55-63.
28. Mattick RP, Breen C, Kimber J, Davoli M (2002). Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev 4: 1-12.
29. Müller MB, Toschi N, Kresse AE, Post A, Keck ME (2000). Long-term repetitive transcranial magnetic stimulation increases the expression of brain-derived neurotrophic factor and cholecystokinin mRNA, but not neuropeptide tyrosine mRNA in specific areas of rat brain. Neuropsychopharmacology 23: 205-215.
30. Nahas Z, Lomarev M, Roberts DR, Shastri A, Lorberbaum JP, Teneback C et al (2001). Unilateral left prefrontal transcranial magnetic stimulation (TMS) produces intensity-dependent bilateral effects as measured by interleaved BOLD fMR1. Biol Psychiatry 50: 712-720.
31. Nazzaro JM, Seeger TF, Gardner EL (1981). Morphine differentially affects ventral tegmental and substantia nigra brain reward thresholds. Pharmacol Biochem Behav 14: 325-331.
32. Nestler EJ (2002). From neurobiology to treatment: progress against addiction. Nat Neurosci 5: 1076-1079.
33. Padberg F, Möller HJ (2003). Repetitive transcranial magnetic stimulation-does it have potential in the treatment of depression? Cns Drugs 17: 383-403.
34. Paxinos G, Watson C (1986). The Rat Brain in Stereotaxic Coordinates. Academic Press: Sydney.
35. Piazza PV, Le Moal M (1997). Glucocorticoids as a biological substrate of reward: physiological pathophysiological implications. Brain Res Rev 25: 359-372.
36. Post A, Keck ME (2001). Transcranial magnetic stimulation as a therapeutic tool in psychiatry: what do we know about the neurobiological mechanisms? J Psychiatr Res 35: 193-215.
37. Robinson TE, Berridge KC (2001). Incentive-sensitization and addiction. Addiction 96: 103-114.
38. Schlaepfer TE, Kosel M, Nemeroff CB (2003). Efficacy of repetitive transcranial magnetic stimulation (rTMS) in the treatment of affective disorders. Neuropsychopharmacology 28: 201-205.
39. Sesack SR (2001). Prefrontal cortical projections to the nucleus accumbens, amygdala, and ventral tegmental area: multiple substrates for prefrontal regulation of ventral striatal function. Biol Psychiatry 49: 9S.
40. Siebner HR, Rothwell J (2003). Transcranial magnetic stimulation: new insights into representational cortical plasticity. Exp Brain Res 148: 1-16.
41. Singewald N, Philippu A (1993). Catecholamine release in the locus coeruleus is modified by experimentally induced changes in haemodynamics. Naunyn Schmiedebergs Arch Pharmacol 347: 21-27.
42. Spanagel R (1995). Modulation of drug-induced sensitization processes by endogenous opioid systems. Behav Brain Res 70: 37-49.
43. Spanagel R, Almeida OF, Shippenberg TS (1993). Long lasting changes in morphine-induced mesolimbic dopamine release after chronic morphine exposure. Synapse 14: 243-245.
44. Spanagel R, Weiss F (1999). The dopamine hypothesis of reward: past and current status. Trends Neurosci 22: 521-527.
45. Strafella AP, Paus T, Barrett J, Dagher A (2001). Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus. J Neurosci 21(RC 157): 1-4.
46. Tsuji S, Akamatsu N (2003). Does transcranial magnetic stimulation improve the motor symptoms of Parkinson disease? J Neurol 250(Suppl 3): 47-50.
47. Taber MT, Fibiger HC (1995). Electrical-stimulation of the prefrontal cortex increases dopamine release in the nucleus-accumbens of the rat-modulation by metabotropic glutamate receptors. J Neurosci 15: 3896-3904.
48. Vanderschuren LJ, De Vries TJ, Wardeh G, Hogenboom FA, Schoffelmeer AN (2001). A single exposure to morphine induces long-lasting behavioural and neurochemical sensitization in rats. Eur J Neurosci 14: 1533-1538.
49. Vanderschuren LJ, Kalivas PW (2000). Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology 151: 99-120.
50. Vezina P, Kalivas PW, Stewart J (1987). Sensitization occurs to the locomotor effects of morphine and the specific mu opioid receptor agonist, DAGO, administered repeatedly to the ventral tegmental area but not to the nucleus accumbens. Brain Res 417: 51-58.
51. Vigano D, Rubino T, Di Chiara G, Ascari I, Massi P, Parolaro D (2003). Mu opioid receptor signaling in morphine sensitization. Neuroscience 117: 921-929.
52. Volkow ND, Fowler JS, Wang GJ, Goldstein RZ (2002). Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies. Neurabiol Learn Mem 78: 610-624.
53. White FJ (1996). Synaptic regulation of mesocorticolimbic dopamine neurons. Annu Rev Neurosci 19: 405-436.
54. Wise RA (1996). Addictive drugs and brain stimulation reward. Annu Rev Neurosci 19: 319-340.
55. Wise RA (1998). Drug-activation of brain reward pathways. Drug Alcohol Depend 51: 13-22.
56. Wise RA, Leone P, Rivest R, Leeb K (1995). Elevations of nucleus accumbens dopamine and DOPAC levels during intravenous heroin self-administration. Synapse 21: 140-148.
57. You ZB, Tzschentke TM, Brodin E, Wise RA (1998). Electrical stimulation of the prefrontal cortex increases cholecystokinin, glutamate, and dopamine release in the nucleus accumbens: an in vivo microdialysis study in freely moving rats. J Neurosci 18: 6492-6500.
58. Zahm DS (2000). An integrative neuroanatomical perspective on some subcortical substrates of adaptive responding with emphasis on the nucleus accumbens. Neurosci Biobehav Rev 24: 85-105.
59. Zangen A, Hyodo K (2002). Transcranial magnetic stimulation induces increases in extracellular levels of dopamine and glutamate in the nucleus accumbens. Neuroreport 13: 2401-2405.
60. Zwanzger P, Ella R, Keck ME, Rupprecht R, Padberg F (2002). Occurrence of delusions during repetitive transcranial magnetic stimulation (rTMS) in major depression. Biol Psychiatry 51: 602-603.